Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis

BACKGROUND: We performed a meta-analysis of cholinesterase inhibitors for patients with Lewy body disorders, such as Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies. METHODS: The meta-analysis included only randomized controlled trials of cholinesterase inhibitors fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsunaga, Shinji, Kishi, Taro, Yasue, Ichiro, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772820/
https://www.ncbi.nlm.nih.gov/pubmed/26221005
http://dx.doi.org/10.1093/ijnp/pyv086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772820/
https://www.ncbi.nlm.nih.gov/pubmed/26221005
http://dx.doi.org/10.1093/ijnp/pyv086

Ejemplares similares